Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
522.65 INR | +1.34% |
|
+10.36% | +13.46% |
18/07 | Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 | CI |
07/05 | Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4 | MT |
Main competitors
Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
0.15% | 1.11% | 33.72x | 3.52x | - | - | - | 56Cr | ||
0.77% | 0.86% | 36.13x | 26.62x | 11.98x | 27.23x | 29.39x | 69TCr | ||
3.15% | 3.25% | 14.63x | 5.17x | 4.31x | 11.78x | 13.12x | 39TCr | ||
3.45% | 3.63% | 27.14x | 54.04x | 6.49x | 13.73x | 14.17x | 33TCr | ||
3.18% | 3.66% | 15.94x | 8.98x | 5.78x | 11.57x | 12.78x | 29TCr | ||
3.82% | 3.91% | 14.37x | 5.44x | 3.52x | 8.72x | 10.02x | 26TCr | ||
3.49% | 3.57% | 16.56x | 5.05x | 4.4x | 10.31x | 11.5x | 22TCr | ||
2.32% | 2.44% | 21.78x | 4.74x | 4.08x | 12x | 12.73x | 21TCr | ||
4.02% | 4.22% | 10.26x | 3.62x | 3.33x | 7.2x | 8.02x | 20TCr | ||
3.25% | 3.42% | 22.54x | 18.04x | 5.77x | 11.13x | 13.09x | 16TCr | ||
6.98% | 7.12% | 11.38x | 1.53x | 2.85x | 6.98x | 8.22x | 14TCr | ||
3% | 3.14% | 19.88x | 6.02x | 5.1x | 9.33x | 11.23x | 13TCr | ||
-.--% | -.--% | 30.62x | 6.08x | 9.11x | 19.37x | 20.25x | 12TCr | ||
4.97% | 5.21% | 11.75x | 1.3x | 2.48x | 8.04x | 8.86x | 12TCr | ||
5.23% | 5.41% | 10.94x | 4.66x | 2.8x | 7.63x | 8.15x | 9.64TCr | ||
3.6% | 1.73% | 26.44x | 5.76x | 8.79x | 17.31x | 18.1x | 7.77TCr | ||
4.83% | 5.13% | 9.56x | 3.7x | 2.14x | 6.35x | 7.19x | 7.32TCr | ||
0.4% | 0.45% | 50.99x | 6.87x | 11.27x | 41.15x | 44.56x | 5.46TCr | ||
4.61% | 4.7% | 27.92x | 1x | 2.33x | 8.59x | 21.68x | 4.62TCr | ||
Average | 3.22% | 3.31% | 21.71x | 9.06x | 5.36x | 13.25x | 15.17x | 19.07TCr | |
Weighted average by Cap. | 2.97% | 3.08% | 21.90x | 14.28x | 6.20x | 14.47x | 15.94x |
- Stock Market
- Equities
- 524348 Stock
- Sector Aarti Drugs Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition